These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38148134)

  • 1. Multicenter study evaluating target attainment of anti-Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients.
    Chanas T; Gibson G; Langenstroer E; Herrmann DJ; Carver TW; Alexander K; Chui SHJ; Rein L; Ha M; Maynard KM; Bamberg K; O'Keefe M; O'Brien M; Gonzalez MC; Hobbs B; Pajoumand M; Peppard WJ
    Pharmacotherapy; 2024 Mar; 44(3):258-267. PubMed ID: 38148134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of anti-factor Xa concentrations using a body mass index-based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients.
    O'Keefe MM; Carver TW; Herrmann DJ; Prom A; Hubbard S; Rein LE; Peppard WJ
    Pharmacotherapy; 2022 Mar; 42(3):216-223. PubMed ID: 35100448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Xa guided enoxaparin dose adjustment improves pharmacologic deep venous thrombosis prophylaxis in burn patients.
    Cronin BJ; Godat LN; Berndtson AE; Pham A; Kolan S; Box K; Lee JG; Costantini TW
    Burns; 2019 Jun; 45(4):818-824. PubMed ID: 30827851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight-based enoxaparin with anti-factor Xa assay-based dose adjustment for venous thromboembolic event prophylaxis in adult trauma patients results in improved prophylactic range targeting.
    Rodier SG; Bukur M; Moore S; Frangos SG; Tandon M; DiMaggio CJ; Ayoung-Chee P; Marshall GT
    Eur J Trauma Emerg Surg; 2021 Feb; 47(1):145-151. PubMed ID: 31471669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a novel blood volume-based enoxaparin dosing guideline for venous thromboembolism prophylaxis in trauma patients.
    Langenstroer EA; Carver TW; Herrmann DJ; O'Keefe MM; Hubbard S; Holschbach L; Rein L; Peppard WJ
    Am J Health Syst Pharm; 2023 Aug; 80(17):1137-1146. PubMed ID: 37256752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
    Bigos R; Solomon E; Dorfman JD; Ha M
    J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievement of goal anti-Xa activity with weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients.
    Taylor A; Huang E; Waller J; White C; Martinez-Quinones P; Robinson T
    Pharmacotherapy; 2021 Jun; 41(6):508-514. PubMed ID: 33864688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Body Mass Index-Based Prophylactic Enoxaparin Dosing in Bariatric Surgery Patients.
    Chang CK; Higgins RM; Rein L; Peppard WJ; Herrmann DJ; Kindel T
    J Surg Res; 2023 Jul; 287():168-175. PubMed ID: 36933548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.
    Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ
    Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.
    Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR
    Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trauma patients with lower extremity and pelvic fractures: Should anti-factor Xa trough level guide prophylactic enoxaparin dose?
    Dhillon NK; Smith EJT; Gillette E; Mason R; Barmparas G; Gewertz BL; Ley EJ
    Int J Surg; 2018 Mar; 51():128-132. PubMed ID: 29367044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients.
    Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R
    J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Adequacy of VTE Prophylaxis Dosing with Enoxaparin for Overweight and Obese Patients on an Orthopedic-Medical Trauma Comanagement Service.
    Perrin A; Sheth H; Snyder V; Dailey H; Jovin F; Smith R
    South Med J; 2023 Apr; 116(4):345-349. PubMed ID: 37011582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight-Based Compared With Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial.
    Bruno AM; Allshouse AA; Campbell HM; Branch DW; Lim MY; Silver RM; Metz TD
    Obstet Gynecol; 2022 Oct; 140(4):575-583. PubMed ID: 36075079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an enoxaparin dosing calculator using burn size and weight.
    Faraklas I; Ghanem M; Brown A; Cochran A
    J Burn Care Res; 2013; 34(6):621-7. PubMed ID: 24043245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients.
    Lin H; Faraklas I; Saffle J; Cochran A
    J Trauma; 2011 Dec; 71(6):1557-61. PubMed ID: 22027887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients.
    Yam L; Bahjri K; Geslani V; Cotton A; Hong L
    Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients: A systematic review and meta-analysis.
    Ebeid A; Cole E; Stallwood-Hall C
    J Trauma Acute Care Surg; 2022 Aug; 93(2):e71-e79. PubMed ID: 35583986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.